CLINICAL_TRIALS
trial_result
· 2022-11-08
Clinical Trial Update: Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating glucosamine and chondroitin for joint symptoms in women taking aromatase inhibitors for breast cancer; trial completed with results pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dawn L. Hershman | Conditions: Breast Cancer, Joint Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08